Evidence map›Paper›PMID 30760249›Full record

ArticleBMC ophthalmology2019

Migraine and increased risk of developing open angle glaucoma: a population-based cohort study.

Jehn-Yu Huang, Chien-Chia Su, Tsing-Hong Wang, I-Ju Tsai

Open access · goldAbstract read
In one paragraph

Article in BMC ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Glaucoma and Systemic Disease.Life (Basel, Switzerland) · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Predictors of Early Onset Glaucoma.Clinical ophthalmology (Auckland, N.Z.) · 2022
    Article
  11. Article
  12. Air Pollutant Particles, PMInternational journal of environmental research and public health · 2021
    Article
  13. Oxidative Stress and the Role of NADPH Oxidase in Glaucoma.Antioxidants (Basel, Switzerland) · 2021
    Review
  14. Article
  15. Review
  16. Increased Incidence of Glaucoma in Sensorineural Hearing Loss: A Population-Based Cohort Study.International journal of environmental research and public health · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jehn-Yu HuangDepartment of Ophthalmology, National Taiwan University Hospital College of Medicine, National Taiwan University, No. 7, Chung-Shan S. Rd., Taipei, Taiwan.
Chien-Chia SuDepartment of Ophthalmology, National Taiwan University Hospital College of Medicine, National Taiwan University, No. 7, Chung-Shan S. Rd., Taipei, Taiwan. chienchiasu@ntu.edu.tw.ORCID http://orcid.org/0000-0002-9220-7599
Tsing-Hong WangDepartment of Ophthalmology, National Taiwan University Hospital College of Medicine, National Taiwan University, No. 7, Chung-Shan S. Rd., Taipei, Taiwan.
I-Ju TsaiDepartment of Ophthalmology, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan.
National Taiwan University · TWNational Taiwan University Hospital · TW

Funding

Ministry of Science and Technology, Taiwan 106-2314-B-002 -130 -MY3National Taiwan University Hospital 106-N3680
6 · The paper itself

Abstract

backgroundMigraine is linked to endothelial dysfunction and is considered to be a systemic vasculopathy. Interestingly, systemic vascular diseases also occur in glaucoma patients and are considered to be vascular risk factors. Whether migraine is simply a concomitant condition in glaucoma patients or a risk factor per se for glaucoma remains unknown. Thus, in the present study, we investigated the risk for open angle glaucoma (OAG) in migraineurs using a 10-year follow-up study that employed a nationwide population-based dataset in Taiwan.

methodsThis retrospective matched-cohort study used data sourced from the Longitudinal Health Insurance Database 2000. We included 17,283 subjects with migraine in the study cohort and randomly selected 69,132 subjects from the database for the comparison group. Each subject in this study was individually traced for a 10-year period to identify those subjects who subsequently received a diagnosis of OAG. The age-adjusted Charlson's comorbidity index (ACCI) score was utilized to compute the burden of comorbidity in each subject. Multivariate regression analysis was used to assess risk factors for OAG in migraineurs. Cox proportional hazards regression was performed to compare the 10-year risk of OAG between the migraineurs and the comparison cohort.

resultsMigraineurs had more vascular comorbidities than the comparison cohort. The overall incidence of OAG (per 1000 person-years) was 1.29 and 1.02, respectively, for migraineurs and the comparison cohort during the 10-year follow-up period. Age, hyperlipidemia, and diabetes mellitus were three significant risk factors for OAG in migraineurs. After adjusting for patients' age and vascular comorbidities, migraineurs were found to have a 1.68-fold (95% confidence interval [CI], 1.20-2.36) greater risk of developing OAG than the comparison cohort, in subjects with an ACCI score of 0. This association became statistically nonsignificant in subjects with ACCI scores of 1-2 or ≥ 3.

conclusionMigraine is associated with a higher risk of OAG for patients with no comorbidity who are aged under 50 years.

Indexed as

AdultCohort StudiesDatabases, FactualFemaleFollow-Up StudiesGlaucoma, Open-AngleHumansIncidenceMaleMiddle AgedMigraine DisordersNational Health ProgramsProportional Hazards ModelsRetrospective StudiesRisk FactorsTaiwanAge-adjusted Charlson comorbidity indexMigraineOpen-angle glaucoma

Identifiers

PMID30760249
PMCPMC6375150
OpenAlexW814761450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.